References
- Le Saux N. Antimicrobial stewardship in daily practice: Managing an important resource. Paediatr Child Health. 2014;19(5):261-270. doi:10.1093/pch/19.5.261
- Ture Z, Güner R, Alp E. Antimicrobial steward-ship in the intensive care unit. J Intensive Med. 2022;3(3):244-253. Published 2022 Nov 15. doi:10.1016/j.jointm.2022.10.001
- Kyriazopoulou E, Giamarellos-Bourboulis EJ. Antimicrobial Stewardship Using Bio-markers: Accumulating Evidence for the Critically Ill. Antibiotics (Basel). 2022;11(3):367. Published 2022 Mar 9. doi:10.3390/antibiotics11030367
- Moniz P, Coelho L, Póvoa P. Antimicrobial Stewardship in the Intensive Care Unit: The Role of Biomarkers, Pharmacokinetics, and Pharmacodynamics. Adv Ther. 2021;38(1):164-179. doi:10.1007/s12325-020-01558-w
- Nora D, Salluh J, Martin-Loeches I, Póvoa P. Bio-marker-guided antibiotic therapy-strengths and limitations. Ann Transl Med. 2017;5(10):208. doi:10.21037/atm.2017.04.04
- Cortegiani A, Antonelli M, Falcone M, et al. Rationale and clinical application of antimicrobial stewardship principles in the intensive care unit: a multidisciplinary statement. J Anesth Analg Crit Care. 2023;3(1):11. Published 2023 May 1. doi:10.1186/s44158-023-00095-6
- Lawrence KL, Kollef MH. Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med. 2009;179(6):434-438. doi:10.1164/rccm.200809-1394CP
- Zilahi G, Artigas A, Martin-Loeches I. What's new in multidrug-resistant pathogens in the ICU?. Ann Intensive Care. 2016;6(1):96. doi:10.1186/s13613-016-0199-4
- Martín-Loeches I, Diaz E, Vallés J. Risks for multidrug-resistant pathogens in the ICU. Curr Opin Crit Care. 2014;20(5):516-524. doi:10.1097/MCC.0000000000000124
- Raut M, Schein J, Mody S, et al. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US. Curr Med Res Opin. 2009;25(9):2151-2157. doi:10.1185/03007990903102743
- Tanaka C, Tagami T, Kuno M, et al; DIANA Study Japanese Group. Evaluation of clinical response to empirical antimicrobial therapy on day 7 and mortality in the intensive care unit: sub-analysis of the DIANA study Japanese data. Acute Med Surg. 2023;10(1):e842. Published 2023 May 17. doi:10.1002/ams2.842
- Vlak I, Samardžić I, Marinović I, et al. Antimicrobial Stewardship and Dose Adjustment of Restricted Antimicrobial Drugs in Hospital Setting. Pharmacy (Basel). 2023;11(2):68. Published 2023 Apr 2. doi:10.3390/pharmacy11020068
- Hughes S, Heard KL, Mughal N, et al. Optimization of antimicrobial dosing in patients with acute kidney injury: a single-centre observational study. JAC Antimicrob Resist. 2022;4(4):dlac080. Published 2022 Jul 25. doi:10.1093/jacamr/dlac080
- Pulcini C, Binda F, Lamkang AS, et al. Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach. Clin Micro-biol Infect. 2019;25(1):20-25. doi:10.1016/j. cmi.2018.03.033
- Kollef MH, Bassetti M, Francois B, et al. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med. 2017;43(9):1187-1197. doi:10.1007/s00134-017-4682-7
- De Waele JJ, Akova M, Antonelli M, et al. Antimicrobial resistance and antibiotic steward-ship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance. Intensive Care Med. 2018;44(2):189-196. doi:10.1007/ s00134-017-5036-1
- Bonten MJ, Weinstein RA. The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol. 1996;17(3):193-200. doi:10.1086/647274
- Kurukulasooriya MRP, Tillekeratne LG, Wijayaratne WMDGB, et al. Methicillin-resistant Staphylococcus aureus: prevalence of and risk factors associated with colonization of patients on admission to the Teaching hospital, Karapitiya. J Univ Ruhuna 2018;6(2):70–75. doi: 10.4038/jur.v6i2.7878
- Reuken PA, Torres D, Baier M, et al. Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis. PLoS One. 2017;12(2):e0172373. Published 2017 Feb 13. doi:10.1371/journal.pone.0172373
- Joung MK, Lee JA, Moon SY, et al. Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care. 2011;15(2):R79. doi:10.1186/cc10072
- Morel J, Casoetto J, Jospé R, et al. De-escalation as part of a global strategy of empiric anti-biotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care. 2010;14(6):R225. doi:10.1186/cc9373
- Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007;60(5):913-920. doi:10.1093/jac/ dkm318
- Williams TA, Ho KM, Dobb GJ, et al. Effect of length of stay in intensive care unit on hospital and long-term mortality of critically ill adult patients. Br J Anaesth. 2010;104(4):459-464. doi:10.1093/bja/aeq025